C. Tyrrell - Concepedia

Author

C. Tyrrell

Also Known As

C J Tyrrell, C Tyrrell, C. J. TYRRELL, C. J. Tyrrell, C. Tyrrell, C.J. Tyrrell, CHRIS J. TYRRELL, CHRIS J. TYRRElL, CHRIS TYRRELL, Chris J. Tyrrell

Publications

Citations

H-Index

Concepts

All Affiliations

Plymouth Hospital AstraZeneca (United Kingdom)Derriford Hospital University of Copenhagen University College London

About

C. Tyrrell is an author at Plymouth Hospital specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	1.1K
2	Engineering	1	1	27
3	Health Sciences	1	1	77
4	Obstetrics	1	1	63
5	Orthopaedics	1	1	17

C. Tyrrell

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
BICALUTAMIDE MONOTHERAPY COMPARED WITH CASTRATION IN PATIENTS WITH NONMETASTATIC LOCALLY ADVANCED PROSTATE CANCER: 6.3 YEARS OF FOLLOWUP Peter Iversen, C. Tyrrell, Amir V. Kaisary, The Journal of Urology	2000	345
A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer * W. Jonat, Anthony Howell, Carl Blomqvist, European Journal of Cancer Megestrol AcetateBreast OncologyOncologyMedicineRandomised Trial	1996	255
Bicalutamide as Immediate Therapy Either Alone or as Adjuvant to Standard Care of Patients with Localized or Locally Advanced Prostate Cancer: First Analysis of the Early Prostate Cancer Program William A. See, Manfred P. Wirth, David G. McLeod, The Journal of Urology	2002	229
Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years Peter Iversen, C. Tyrrell, Amir V. Kaisary, Urology Surgical OncologyUrologyGenitourinary CancerMedicineMedian Follow-up	1998	164
A Multicenter Randomized Trial Comparing the Luteinizing Hormone-Releasing Hormone Analogue Goserelin Acetate Alone and with Flutamide in the Treatment of Advanced Prostate Cancer C. Tyrrell, J. E. Altwein, F. Klippel, The Journal of Urology	1991	98
Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression Manfred P. Wirth, C. Tyrrell, Michael B. Wallace, Urology UrologyDisease ProgressionGenitourinary CancerMedicineAdvanced Prostate Cancer	2001	81
The Response of Lymph Node Metastases of Testicular Teratoma to Radiation Therapy C. Tyrrell, Michael Peckham British Journal of Urology Distant SpreadLymphoid NeoplasiaUrologySurgical OncologyTumour Eradication	1976	77
Bicalutamide (‘Casodex’) 150mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: Results from the randomised Early Prostate Cancer Programme C. Tyrrell, H. Payne, William A. See, Radiotherapy and Oncology Radiation MedicineUrologyMedicineMetronomic TherapyAdvanced Prostate Cancer	2005	71
Efficacy and Tolerability of Radiotherapy as Treatment for Bicalutamide-induced Gynaecomastia and Breast Pain in Prostate Cancer Hendrik Van Poppel, C. Tyrrell, Karin Haustermans, European Urology UrologyBicalutamide-induced GynaecomastiaBreast PainRadiation TherapyMedicine	2004	63
The addition of bicalutamide 150 mg to radiotherapy significantly improves overall survival in men with locally advanced prostate cancer William A. See, C. Tyrrell Journal of Cancer Research and Clinical Oncology UrologyRadiation MedicineRadiation TherapyOverall SurvivalMedicine	2006	63

Page 1